United States Endoscopy Devices Market Size and Forecast 2026–2034

The United States endoscopy devices market is entering a transformative decade marked by technological breakthroughs, expanding clinical applications, and rising disease burden. According to Renub Research, the market is projected to grow from US$ 12.17 Billion in 2025 to US$ 22.04 Billion by 2034, registering a Compound Annual Growth Rate (CAGR) of 6.82% from 2026 to 2034.

This sustained expansion reflects a broader shift toward minimally invasive diagnostics and treatment, supported by an aging population, rising gastrointestinal (GI) disorders, and continuous advancements in imaging and robotic-assisted technologies.

Download Free Sample Report:https://www.renub.com/request-sample-page.php?gturl=united-states-endoscopy-devices-market-p.php

United States Endoscopy Devices Market Overview

Endoscopy devices are advanced medical tools that allow physicians to examine internal organs without large surgical incisions. An endoscope — a thin, flexible or rigid tube equipped with a camera and light source — is inserted through natural openings or small incisions to diagnose and treat conditions.

Common endoscopic instruments include:

  • Gastrointestinal endoscopes

  • Bronchoscopes

  • Colonoscopes

  • Laparoscopes

  • Urological and neuroendoscopic devices

In the United States, endoscopy plays a central role in diagnosing cancers, inflammatory conditions, respiratory diseases, and digestive disorders. The appeal lies in its minimally invasive nature — offering reduced pain, faster recovery, and lower complication rates compared to open surgery.

Preventive screening programs, especially colonoscopy for colorectal cancer detection, are further accelerating demand. The strong U.S. healthcare infrastructure and rapid technology adoption make the country one of the most advanced endoscopy markets globally.

Key Growth Drivers

Rising Prevalence of Gastrointestinal Diseases and Cancer

The growing burden of GI diseases and cancer remains a primary catalyst for market growth.

Recent healthcare data highlights the scale of impact:

  • GI healthcare expenditures reached US$ 111.8 billion.

  • 14.5 million emergency department visits were linked to GI symptoms.

  • 2.9 million hospital admissions were GI-related.

  • 315,065 new GI cancer cases were diagnosed.

  • 281,413 deaths were attributed to GI diseases.

  • Approximately 23.5 million GI endoscopies were performed in 2022.

  • In 2023, NIH allocated US$ 3.6 billion toward GI research.

  • In 2025, an estimated 2,041,910 new cancer cases and 618,120 cancer deaths are expected in the U.S.

Endoscopy enables early detection, biopsy collection, tumor identification, and polyp removal. Early diagnosis improves survival rates and reduces long-term treatment costs.

As preventive screening becomes more common and awareness increases, demand for advanced endoscopic devices continues to climb steadily.

Growing Demand for Minimally Invasive Procedures

Patient preference is shifting decisively toward minimally invasive techniques. Endoscopic procedures offer:

  • Smaller incisions

  • Less postoperative pain

  • Reduced hospital stays

  • Faster recovery

  • Lower risk of complications

Hospitals and ambulatory surgery centers increasingly adopt endoscopic systems to deliver efficient outpatient care.

Technological upgrades such as high-definition imaging, flexible scopes, and robotic-assisted endoscopy are enhancing safety and procedural precision.

In July 2025, BVI introduced its FDA-approved Leos™ Laser Endoscopy Ophthalmic System, with the first procedure performed in New York — highlighting how innovation continues to reshape clinical practice.

Technological Advancements and Innovation

Rapid technological evolution is redefining the competitive landscape.

Modern endoscopy systems now include:

  • High-definition and 4K imaging

  • Capsule endoscopy for non-invasive GI imaging

  • Robotic-assisted endoscopy

  • Artificial intelligence-assisted lesion detection

  • Enhanced visualization and navigation systems

  • Cloud-based data integration

In January 2025, AnX Robotica received FDA clearance for the NaviCam capsule endoscopy system, expanding wireless small-bowel diagnostics capabilities.

AI integration is particularly transformative, enabling real-time detection of abnormalities during procedures, thereby improving accuracy and reducing missed diagnoses.

Continuous innovation ensures sustained growth and high replacement demand within healthcare facilities.

Market Challenges

High Cost of Equipment and Procedures

Advanced endoscopy systems — including imaging processors, scopes, and visualization platforms — require substantial capital investment. Maintenance and technology upgrades add to operational expenses.

While insurance often covers procedures, out-of-pocket expenses remain a concern for uninsured or underinsured patients.

Cost pressures may limit adoption among smaller healthcare centers, especially when upgrading to AI-integrated or robotic systems.

Infection Risks and Regulatory Compliance

Reusable endoscopes require rigorous sterilization to prevent cross-contamination. Improper disinfection can result in healthcare-associated infections, affecting patient safety and institutional reputation.

Strict regulatory standards, including FDA approvals and quality compliance, extend development timelines and increase manufacturing costs.

Manufacturers must invest heavily in research, testing, and documentation before launching new devices.

Segment Insights

Mechanical Endoscopic Equipment Devices

Mechanical tools such as forceps, snares, scissors, dilators, and retrieval baskets are vital in diagnostic and therapeutic procedures.

These devices facilitate:

  • Tissue biopsies

  • Polyp removal

  • Foreign body extraction

  • GI and respiratory disease treatment

Technological advancements have improved durability, flexibility, and safety, enhancing clinical efficiency. Rising procedure volumes are expected to drive steady demand.

Bronchoscopy Devices Market

Bronchoscopy is critical for diagnosing lung infections, chronic obstructive pulmonary disease (COPD), and lung cancer.

Rising respiratory diseases — particularly among aging populations and smokers — are boosting demand.

High-definition bronchoscopes and advanced navigation systems are improving early lung cancer detection and minimally invasive treatment outcomes.

Hospitals and respiratory care centers continue to invest in next-generation bronchoscopy equipment.

Laparoscopy Devices Market

Laparoscopy is widely used in gallbladder removal, hernia repair, and gynecological surgery.

Benefits include:

  • Faster recovery

  • Reduced surgical trauma

  • Shorter hospitalization

Robotic-assisted laparoscopy and advanced visualization systems are enhancing procedural accuracy and expanding surgical applications.

As outpatient surgery grows, laparoscopy equipment demand remains strong.

Hospitals Segment

Hospitals dominate the U.S. endoscopy devices market due to high procedure volumes and access to advanced infrastructure.

They utilize endoscopy systems for diagnosing and treating GI disorders, cancer, respiratory diseases, and urological conditions.

Rising healthcare expenditure and emphasis on early detection further strengthen hospital demand.

State-Level Insights

California

California’s advanced healthcare infrastructure, research institutions, and medical device manufacturers position it as a major growth hub.

High adoption of robotic-assisted and AI-enabled endoscopy systems is driving innovation.

Increasing chronic disease prevalence and expansion of ambulatory surgical centers further support growth.

New York

New York’s aging population and strong hospital network fuel rising endoscopy demand.

Preventive screening initiatives — especially colonoscopy programs — contribute to procedure growth.

In March 2024, Scivita Medical Technology partnered with Boston Scientific Corporation to expand imaging equipment distribution and development.

New Jersey

New Jersey benefits from a strong medical device manufacturing presence and well-developed healthcare infrastructure.

In March 2024, NTT Corporation partnered with Olympus Corporation to pilot a cloud-based endoscopy imaging solution.

Rising GI disorders and innovation investments continue to propel the state market.

Washington

Washington’s healthcare innovation ecosystem supports rapid adoption of advanced diagnostic tools.

In May 2025, Olympus received FDA 510(k) clearance for its EZ1500 endoscopes with Extended Depth of Field technology.

Growing outpatient centers and preference for minimally invasive procedures are reinforcing market growth.

Market Segmentation

By Product Type

  • Endoscopes

  • Visualization & Documentation Systems

  • Mechanical Endoscopic Equipment

  • Accessories

  • Others

By Application

  • Bronchoscopy

  • Arthroscopy

  • Laparoscopy

  • Urology Endoscopy

  • Neuroendoscopy

  • Gastrointestinal Endoscopy

  • Gynecology Endoscopy

  • ENT Endoscopy

  • Others

By Hygiene

  • Single Use

  • Reprocessing

  • Sterilization

By End-User

  • Hospitals

  • Ambulatory Surgery Centers

  • Others

Top States Covered

California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, Maryland, Colorado, Tennessee, Indiana, Arizona, Minnesota, Wisconsin, Missouri, Connecticut, South Carolina, Oregon, Louisiana, Alabama, Kentucky, and Rest of United States.

Competitive Landscape

Leading companies are focusing on innovation, AI integration, robotic platforms, and single-use device expansion.

Major players include:

  • Johnson & Johnson

  • Stryker

  • Boston Scientific

  • CONMED

  • Medtronic Plc

  • Fujifilm Holdings

  • Smith and Nephew

Each company is analyzed from five viewpoints:

  • Overview

  • Key Persons

  • Recent Developments

  • SWOT Analysis

  • Revenue Analysis

Report Details

  • Base Year: 2025

  • Forecast Period: 2026–2034

  • Market Size Unit: US$ Billion

  • Segments Covered: Product Type, Application, Hygiene, End-User, States

Final Thoughts

The United States endoscopy devices market stands at the intersection of technological innovation and rising healthcare demand. With Renub Research projecting growth from US$ 12.17 Billion in 2025 to US$ 22.04 Billion by 2034, the sector is poised for sustained expansion.

Rising GI disorders, increasing cancer screenings, preference for minimally invasive surgery, and AI-driven diagnostics are reshaping the landscape. While cost pressures and regulatory complexities remain challenges, continuous innovation and expanding outpatient care models will likely drive long-term growth.

As precision medicine and early disease detection become healthcare priorities, endoscopy devices will remain essential tools in improving patient outcomes across the United States.